EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Organ‐on‐Chip Platform for Simulating Drug Metabolism Along the Gut–Liver Axis

Mara Lucchetti iD, Kehinde Oluwasegun Aina iD, Léa Grandmougin iD, Christian Jäger iD, Pau Pérez Escriva iD, Elisabeth Letellier iD, Alexander S Mosig iD, Paul Wilmes iD

Advanced Healthcare Materials · 2024-08 · 13 (20)

DOI: 10.1002/adhm.202303943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.03.2024. Verfasst von Mara Lucchetti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, L-4362, Luxembourg. Hauptthemen laut MEDLINE: Irinotecan, Liver, Gastrointestinal Microbiome. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Fonds National de la Recherche Luxembourg and Fondation Cancer, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human microbiome significantly influences drug metabolism through the gut–liver axis, leading to modified drug responses and potential toxicity. Due to the complex nature of the human gut environment, the understanding of microbiome‐driven impacts on these processes is limited. To address this, a multiorgan‐on‐a‐chip (MOoC) platform that combines the human microbial‐crosstalk (HuMiX) gut‐on‐chip (GoC) and the Dynamic42 liver‐on‐chip (LoC), mimicking the bidirectional interconnection between the gut and liver known as the gut–liver axis, is introduced. This platform supports the viability and functionality of intestinal and liver cells. In a proof‐of‐concept study, the metabolism of irinotecan, a widely used colorectal cancer drug, is imitated within the MOoC. Utilizing liquid chromatography coupled to tandem mass spectrometry (LC‐MS/MS), irinotecan metabolites are tracked, confirming the platform's ability to represent drug metabolism along the gut–liver axis. Further, using the authors’ gut–liver platform, it is shown that the colorectal cancer‐associated gut bacterium, Escherichia coli , modifies irinotecan metabolism through the transformation of its inactive metabolite SN‐38G into its toxic metabolite SN‐38. This platform serves as a robust tool for investigating the intricate interplay between gut microbes and pharmaceuticals, offering a representative alternative to animal models and providing novel drug development strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IrinotecanLiverGastrointestinal MicrobiomeHumansLab-On-A-Chip DevicesTandem Mass SpectrometryChromatography, Liquid

Stichwörter der Autor:innen

Escherichia colidrug metabolismgut microbiomeirinotecanmultiorgan‐on‐chiporgan‐on‐chip

Substanzen

Irinotecan

Autor:innen und Institutionen

  • Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, L-4362, Luxembourg.
  • Institute of Biochemistry II, Jena University Hospital, D-07747, Jena, Germany.
  • Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Belval, L-4362, Luxembourg.

ORCID-Profile: Mara Lucchetti, Kehinde Oluwasegun Aina, Léa Grandmougin, Christian Jäger, Pau Pérez Escriva, Elisabeth Letellier, Alexander S Mosig, Paul Wilmes

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Fonds National de la Recherche Luxembourg and Fondation Cancer
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung
  • H2020 Marie Skłodowska-Curie Actions

Zitieren

APA

Lucchetti, M., Aina, K. O., Grandmougin, L., Jäger, C., Pérez Escriva, P., Letellier, E., Mosig, A. S., & Wilmes, P. (2024). An Organ‐on‐Chip Platform for Simulating Drug Metabolism Along the Gut–Liver Axis. Advanced Healthcare Materials, 13(20). https://doi.org/10.1002/adhm.202303943

Vancouver

Lucchetti M, Aina KO, Grandmougin L, Jäger C, Pérez Escriva P, Letellier E, et al. An Organ‐on‐Chip Platform for Simulating Drug Metabolism Along the Gut–Liver Axis. Advanced Healthcare Materials. 2024;13(20). doi:10.1002/adhm.202303943

BibTeX
@article{Lucchetti2024,
  author = {Lucchetti, Mara and Aina, Kehinde Oluwasegun and Grandmougin, Léa and Jäger, Christian and Pérez Escriva, Pau and Letellier, Elisabeth and Mosig, Alexander S and Wilmes, Paul},
  title = {An Organ‐on‐Chip Platform for Simulating Drug Metabolism Along the Gut–Liver Axis},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {20},
  doi = {10.1002/adhm.202303943}
}
Kostenlos starten →